Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

  • Post published:April 12, 2022
  • Post category:Press Release
Read more about the article Novamind Partners with Merck for New Treatment-Resistant Depression Trial

Novamind Partners with Merck for New Treatment-Resistant Depression Trial

  • Post published:March 18, 2021
  • Post category:Press Release
Read more about the article Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

  • Post published:March 1, 2021
  • Post category:Press Release
Read more about the article Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

  • Post published:February 22, 2021
  • Post category:Press Release
Read more about the article Novamind Announces Marketing Services Agreements

Novamind Announces Marketing Services Agreements

  • Post published:January 26, 2021
  • Post category:Press Release
Read more about the article Novamind Expands Psychedelic Medicine Access in Utah

Novamind Expands Psychedelic Medicine Access in Utah

  • Post published:January 13, 2021
  • Post category:Press Release
Read more about the article Novamind Completes Reverse Takeover Transaction

Novamind Completes Reverse Takeover Transaction

  • Post published:December 24, 2020
  • Post category:Press Release
Read more about the article Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

  • Post published:December 22, 2020
  • Post category:Press Release
Read more about the article Novamind Closes Oversubscribed CAD$10 Million Private Placement

Novamind Closes Oversubscribed CAD$10 Million Private Placement

  • Post published:November 23, 2020
  • Post category:Press Release
Read more about the article Novamind and Hinterland Metals Enter into Amalgamation Agreement

Novamind and Hinterland Metals Enter into Amalgamation Agreement

  • Post published:November 17, 2020
  • Post category:Press Release

End of content

No more pages to load

Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More